Boothbay Fund Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,000
| Closed | -$126K | – | 1401 |
|
|
2023
Q4 | $126K | Sell |
14,000
-163
| -1% | -$1.47K | ﹤0.01% | 1240 |
|
|
2023
Q3 | $110K | Buy |
+14,163
| New | +$110K | ﹤0.01% | 1351 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1572 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1867 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1679 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1652 |
|
|
2020
Q3 | – | Sell |
-35,638
| Closed | -$579K | – | 911 |
|
|
2020
Q2 | $579K | Buy |
35,638
+138
| +0.4% | +$2.24K | 0.04% | 450 |
|
|
2020
Q1 | $515K | Sell |
35,500
-50,428
| -59% | -$732K | 0.04% | 387 |
|
|
2019
Q4 | $1.74M | Buy |
+85,928
| New | +$1.74M | 0.15% | 156 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 672 |
|
|
2019
Q2 | – | Sell |
-80,000
| Closed | -$520K | – | 635 |
|
|
2019
Q1 | $520K | Buy |
+80,000
| New | +$520K | 0.05% | 291 |
|
|
2018
Q4 | – | Sell |
-77,913
| Closed | -$517K | – | 579 |
|
|
2018
Q3 | $517K | Buy |
77,913
+41,913
| +116% | +$278K | 0.05% | 260 |
|
|
2018
Q2 | $203K | Buy |
+36,000
| New | +$203K | 0.02% | 498 |
|
|
2017
Q4 | – | Sell |
-12,726
| Closed | -$80K | – | 630 |
|
|
2017
Q3 | $80K | Buy |
+12,726
| New | +$80K | 0.01% | 473 |
|
|
2017
Q2 | – | Sell |
-17,614
| Closed | -$129K | – | 580 |
|
|
2017
Q1 | $129K | Buy |
+17,614
| New | +$129K | 0.02% | 568 |
|
|
2016
Q4 | – | Sell |
-16,345
| Closed | -$49K | – | 685 |
|
|
2016
Q3 | $49K | Buy |
+16,345
| New | +$49K | 0.01% | 599 |
|